AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2010
May 13, 2010
30826_dirs_2010-05-13_6cf15e2c-23e0-42a0-ae66-e2efa57623a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2009-09-11
Reporting Person: Goldberg Alfred Lewis (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-09-11 | Stock Option (Right to Buy) | $4.96 | A | 20000 | Acquired | 2019-09-11 | Common Stock (20000) | Direct |
Footnotes
F1: Award represents Annual Board Options issued each September to each non-employee director. Awards vest in full one year from grant date on September 11, 2010.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23